New EU regulation has made the medtech industry turn to the US

As a direct consequence of new EU regulation for the medtech industry, firms have started to launch in the US before Europe, which wasn’t always the case previously, says the chief executive of industry association Medtech Europe.

Serge Bernasconi, CEO of Medtech Europe | Photo: PR/Medtech Europe

New European requirements for medical devices have meant that the medtech industry has begun launching products in the US before Europe, according to Serge Bernasconi, the chief executive of industry organization Medtech Europe.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs